Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
Abstract: Background: In acute myeloid leukemia (AML), accurate detection of minimal residual disease (MRD) enables better risk‐stratified therapy. There are few studies, however, on the monitoring of multiple fusion transcripts and evaluation of their accuracy as indicators of MRD at multiple time...
| Publicado en: | Pediatrics International Vol. 60; no. 1; pp. 41 - 47 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Jan2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |